Epidemiological studies have shown that higher risk for prostate cancer is perhaps due to environmental (especially diet) rather than genetic differences. There is an association between decreased prostate cancer risk and increased soy consumption (Herbert JR, et al. JNCI 90: 1637-1647, 1998). The soy isoflavone, genistein is believed to be the primary anti-cancer agent found in whole grain cereal food, seeds and soybean products, which may play an important role in the prevention and/or treatment of human prostate cancer. In preliminary studies, we found that genistein inhibits the growth of prostate cancer cell lines with concomitant G2/M cell cycle arrest, up- regulation of p21WAF1 and down-regulation of Cyclin-B and Bcl-2, which may be responsible for the induction of apoptosis observed in genistein treated cells. Furthermore, we also observed down regulation of NF-kappaB function in both androgen responsive as well as androgen non-responsive cell lines. The down regulation in NF-kappaB was found to be concomitant with the down regulation of androgen receptor (AR) and prostate specific antigen (PSA) gene transcription in androgen responsive cells. The down regulation of AR and PSA, and the observed inhibition of cell growth and induction of apoptosis may be mediated by the inactivation of the NF-kappaB pathway. We hypothesize that genistein induces cell growth inhibition and apoptosis by inhibiting NF-kappaB and G2/M cell cycle progression. We also hypothesize that genistein abrogates NF-kappaB function resulting in the down regulation of AR and induction of apoptosis in androgen responsive cells. In this proposal, we will investigate cell growth and apoptotic processes in genistein treated prostate cancer cells by analyzing parameters of cell growth and apoptosis (p21, p53, cyclin B, CDK 1, and Bcl-2/Bax family members) using Northern and Western blot analysis. We will also investigate how genistein can mediate these effects through down regulation of NF-kappaB, AR and PSA by analyzing levels and activity of key kinase molecules and associated mechanisms that are involved in the NF-kappaB signaling pathway. Moreover, we will employ gene transfection studies as well as transfection of AR and PSA reporter constructs to delineate whether the effects of genistein is directly mediated by the down regulation of NF-kappaB, AR and PSA. These results will be compared to those obtained from normal prostate epithelial cells, and the results of this study will elucidate the molecular mechanism(s) by which genistein exerts its biological effects on prostate epithelial cells. In addition, we also propose to test the anti-tumor activity of genistein in prostate cancer animal models and investigate whether the molecular alterations in animal tumors are similar to those observed in vitro.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA083695-04
Application #
6755970
Study Section
Metabolic Pathology Study Section (MEP)
Program Officer
Crowell, James A
Project Start
2001-07-12
Project End
2006-06-30
Budget Start
2004-07-01
Budget End
2006-06-30
Support Year
4
Fiscal Year
2004
Total Cost
$216,423
Indirect Cost
Name
Wayne State University
Department
Pathology
Type
Schools of Medicine
DUNS #
001962224
City
Detroit
State
MI
Country
United States
Zip Code
48202
Kong, Dejuan; Sethi, Seema; Li, Yiwei et al. (2015) Androgen receptor splice variants contribute to prostate cancer aggressiveness through induction of EMT and expression of stem cell marker genes. Prostate 75:161-74
Ahmad, Aamir; Li, Yiwei; Bao, Bin et al. (2014) Epigenetic regulation of miRNA-cancer stem cells nexus by nutraceuticals. Mol Nutr Food Res 58:79-86
Li, Yiwei; Ahmad, Aamir; Kong, Dejuan et al. (2014) Recent progress on nutraceutical research in prostate cancer. Cancer Metastasis Rev 33:629-40
Sethi, Sajiv; Li, Yiwei; Sarkar, Fazlul H (2013) Regulating miRNA by natural agents as a new strategy for cancer treatment. Curr Drug Targets 14:1167-74
Ahmad, Aamir; Biersack, Bernhard; Li, Yiwei et al. (2013) Perspectives on the role of isoflavones in prostate cancer. AAPS J 15:991-1000
Li, Yiwei; Kong, Dejuan; Ahmad, Aamir et al. (2013) Pancreatic cancer stem cells: emerging target for designing novel therapy. Cancer Lett 338:94-100
Li, Yiwei; Kong, Dejuan; Ahmad, Aamir et al. (2013) Antioxidant function of isoflavone and 3,3'-diindolylmethane: are they important for cancer prevention and therapy? Antioxid Redox Signal 19:139-50
Kong, Dejuan; Heath, Elisabeth; Chen, Wei et al. (2012) Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatment. Am J Transl Res 4:14-23
Li, Yiwei; Maitah, Ma'in Y; Ahmad, Aamir et al. (2012) Targeting the Hedgehog signaling pathway for cancer therapy. Expert Opin Ther Targets 16:49-66
Kashat, Maria; Azzouz, Lyna; Sarkar, Shaan H et al. (2012) Inactivation of AR and Notch-1 signaling by miR-34a attenuates prostate cancer aggressiveness. Am J Transl Res 4:432-42

Showing the most recent 10 out of 67 publications